The Leadership Team at Step Pharma is responsible for defining the strategic vision and direction of the company, overseeing the development and commercialization of its novel nucleotide synthesis inhibitors. They collaborate to align scientific research with business objectives, manage financial resources, and foster innovation, ensuring that the therapy effectively targets immune modulation in T and B cell populations. Their combined expertise drives the company's mission to revolutionize treatment options in immunology.